date,action,name,rate,target
Oct-23-18,Resumed,BofA/Merrill,Underperform,$53
Mar-01-19,Upgrade,Goldman,Neutral to Buy,$66
Mar-11-19,Reiterated,Barrington Research,Outperform,$64 to $55
